Catalyst Brief

← Calendar

Readoutin 135d

Boehringer Ingelheim — Nerandomilast

Phase 3 primary completion: A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases.

Date
Apr 2027
Type
Readout
Indication
Interstitial Lung Diseases

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.

More from Boehringer Ingelheim

  1. Dec2026